Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof
US-11208386-B2 · Dec 28, 2021 · US
US12448358B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12448358-B2 |
| Application number | US-202017622200-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 26, 2020 |
| Priority date | Jul 3, 2019 |
| Publication date | Oct 21, 2025 |
| Grant date | Oct 21, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel inhibitors or inactivators of protein arginine deiminase 1, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use thereof.
Opening claim text (preview).
What is claimed is: 1. A compound having the structural formula (I), wherein each of R a and R b is H or D; X is a halogen atom; R 2 is selected from the group consisting of: H, OH or OCH 3 ; R 4 is selected from the group consisting of: H, halogen, ethynyl (HC≡C—) each of R 3 and R 5 is I; R 6 is H or R; and each R is independently a C 1-6 alkyl, or a pharmaceutically acceptable salt thereof. 2. The compound of claim 1 , wherein each of R a and R b is H. 3. The compound of claim 1 , wherein X is F. 4. The compound of claim 1 , wherein X is Cl. 5. The compound of claim 1 , wherein R 2 is OH. 6. The compound of claim 5 , wherein R 4 is H. 7. The compound of claim 6 , wherein R 6 is H. 8. The compound of claim 1 , wherein R 4 is a halogen atom. 9. The compound of claim 1 , in the form of a salt. 10. A pharmaceutical composition comprising a compound of claim 1 . 11. A unit dosage form comprising a pharmaceutical composition according to claim 10 . 12. A method for inhibiting or inactivating protein arginine deiminase 1 (PAD1), comprising administering to a subject in need thereof a pharmaceutical composition of claim 10 .
Drugs for immunological or allergic disorders · CPC title
Antineoplastic agents · CPC title
Feminine contraceptives · CPC title
Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Radicals substituted by nitrogen atoms (by nitro radicals C07D235/10) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.